3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
Conditions
Prostatic Neoplasms
142
Breast Neoplasms
97
Lung Neoplasms
72
Brain Neoplasms
67
Glioblastoma
59
Carcinoma, Non-Small-Cell Lung
54
Glioma
52
Pancreatic Neoplasms
39
Neoplasms
39
Neoplasm Metastasis
36
Colorectal Neoplasms
31
Carcinoma, Hepatocellular
30
Lymphoma, Large B-Cell, Diffuse
27
Carcinoma, Renal Cell
27
Multiple Myeloma
26
Squamous Cell Carcinoma of Head and Neck
25
Rectal Neoplasms
21
Melanoma
21
Ovarian Neoplasms
20
Astrocytoma
20
Urinary Bladder Neoplasms
18
Lymphoma, Follicular
18
Uterine Cervical Neoplasms
17
Colonic Neoplasms
17
Head and Neck Neoplasms
16
Lymphoma
15
Esophageal Neoplasms
15
Sarcoma
14
Lymphoma, Mantle-Cell
14
Lymphoma, B-Cell
14
Interventions
siltuximab
4
fludarabine
3
Cyclophosphamide
3
fludarabine phosphate
2
Interleukin 1 Receptor Antagonist Protein
2
AP 1903 reagent
2
tocilizumab
1
talquetamab
1
axicabtagene ciloleucel
1
Neuropsychological Tests
1
Metoprolol
1
Magnetic Resonance Spectroscopy
1
Leukapheresis
1
Infliximab
1
Etanercept
1
Dexamethasone
1
Contrast Media
1
Calcium Dobesilate
1
Blood Specimen Collection
1
Bendamustine Hydrochloride
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Cytokine Release Syndrome
×
Magnetic Resonance Spectroscopy
×
Clear all
NCT05510596
2024-08-09
MR-ICANS
University Hospital, Montpellier
Phase NA
Completed
25 enrolled